首页> 外文会议>Conference on Design of Circuits and Integrated Systems >Glioblastoma: Pre-treatment geometry and texture of postcontrast T1 MRI matter
【24h】

Glioblastoma: Pre-treatment geometry and texture of postcontrast T1 MRI matter

机译:胶质母细胞瘤:PERTCONTRAST的预处理几何和纹理T1 MRI物质

获取原文

摘要

The potential of tumor's volumetric and texture measures obtained from pretreatment magnetic resonance imaging (MRI) sequences of glioblastoma (GBM) patients as predictors of clinical outcome has been controversial. Mathematical models of GBM growth have suggested a relation between tumor's geometry and its aggressiveness. Multicenter retrospective clinical studies were designed to study geometrical and 3D textural measures on pretreatment postcontrast T1 MRIs of 117 and 79 GBM patients respectively. Clinical variables were collected, tumors segmented and measures computed. Kaplan-Meier and univariate Cox survival analysis showed that spherical contrast enhancing width (p=0.007, HR=1.749) and geometric heterogeneity of the contrast enhancing rim (p=0.015, HR=1.646) were the outstanding parameters in terms of overall survival. Patients with tumors having small geometric heterogeneity and/or spherical rim widths had significantly better prognosis. Regarding 3D textural measures, the co-occurrence matrix feature Entropy showed a gain in median survival for the favorable subgroup of 8.22 months respectively (p=0.013). Patients with tumors having small entropy values had significantly worst prognosis. These geometrical and texture imaging biomarkers have a strong individual and combined prognostic value for GBM patients. “Gliomator” is suggested as a GBM prognostic classifier based on the combined use of geometrical and texture information.
机译:从预处理磁共振成像(GBM)患者的预处理磁共振成像(MRI)序列获得的肿瘤体积和质地措施的潜力是临床结果预测因子的争议。 GBM Grower的数学模型表明肿瘤几何形状与其侵略性之间的关系。多中心回顾性临床研究旨在研究几何和3D纹理措施,分别对预处理的预处理后施用T1 MRIS分别为117和79英镑患者。收集临床变量,肿瘤细分和计算措施。 Kaplan-Meier和单变量的Cox存活分析表明,球面对比增强宽度(P = 0.007,HR = 1.749)和对比度增强边缘的几何异质性(P = 0.015,HR = 1.646)是整体存活方面的出色参数。具有小几何异质性和/或球形轮辋宽度的肿瘤患者具有明显更好的预后。关于3D纹理措施,共发生矩阵特征熵显示出8.22个月的有利亚组中位生存期的增益(P = 0.013)。具有小熵值的肿瘤患者具有明显最差的预后。这些几何和纹理成像生物标志物具有强大的个体和组合的GBM患者的预后价值。基于几何和纹理信息的组合使用,建议“胶质剂”作为GBM预后分类器。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号